GOP Congresswoman Hails Cannabis Rescheduling, Cautions Against Broader Drug Decriminalization

At a recent hearing before the House Education and the Workforce Committee, Representative Lori Chavez-DeRemer (R-OR) expressed her support for the federal rescheduling of marijuana. She specifically addressed U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra, commending the decision to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) as “really good welcoming news.”

Caution on Drug Decriminalization

However, amidst the discussion on marijuana rescheduling, Chavez-DeRemer issued a warning against broader drug decriminalization efforts. She pointedly referenced Oregon’s now-overturned Measure 110, which decriminalized all drugs simultaneously, labeling it as “not a good plan.”

Oregon’s Experience

Referencing Oregon’s experience with Measure 110, Chavez-DeRemer highlighted concerns about increased drug availability on the streets and in the open market. She emphasized the importance of avoiding similar mistakes at the national level, urging Secretary Becerra to commit to evidence-based drug policy approaches.

Secretary Becerra’s Response

In response, Secretary Becerra acknowledged awareness of Measure 110 but admitted to being unfamiliar with its specifics. He emphasized the agency’s commitment to evidence-based decision-making and expressed willingness to collaborate with lawmakers on drug policy issues.

Federal Approach and Legislation

While the Biden administration has initiated a marijuana scheduling review, it is not actively pursuing drug decriminalization at this time. Chavez-DeRemer referenced the Strengthening the Tenth Amendment Through Entrusting States (STATES) 2.0 Act, a bill she is cosponsoring. This legislation seeks to end federal marijuana prohibition in legal states, facilitate interstate cannabis commerce, and establish a federal tax-and-regulate framework for the industry.

Representative Lori Chavez-DeRemer’s stance reflects a nuanced approach to drug policy, supporting marijuana rescheduling while cautioning against broader decriminalization measures. As federal and state-level discussions on drug policy continue, collaboration and evidence-based decision-making will be crucial in shaping future legislation.